Northwest Arkansas Metsquerade

The NWA Metsquerade is a fundraiser for Metavivor, a non-profit organization that uses 100% of donations for metastatic breast cancer research. This fundraiser has raised over $880,000 since 2016 including monies raised from the annual NWA Metsquerade, Annual Runway IV Reseach, and National Metaribbon Challenge, among others.  The team is closing in on a $1,000,000 raised and are excited about this big milestone in fundraising.

Event details TBD!

Triangle Metsquerade

The Triangle Metsquerade is a fundraiser for Metavivor, a non-profit organization that uses 100% of donations for metastatic breast cancer research. METAvivor is dedicated to the specific fight of women and men living with stage IV metastatic breast cancer. At the time of METAvivor’s founding, no organization was dedicated to funding research for the disease and no patient groups were speaking out about the dearth of stage 4 cancer research. While more and more people have taken up the cry for more stage 4 research, METAvivor remains the sole US organization dedicated to awarding annual metastatic breast cancer research grants.

AACR 2019 Annual Meeting

The AACR Annual Meeting program covers the latest discoveries across the spectrum of cancer research—from population science and prevention; to cancer biology, translational, and clinical studies; to survivorship and advocacy—and highlights the work of the best minds in research and medicine from institutions all over the world.

Patient advocates interested in attending, should check out the 21st Annual Scientist↔Survivor Program at the Annual Meeting

Southwest Florida Metsquerade

The Metsquerade is a fundraising event to benefit Metavivor. METAvivor is dedicated to the specific fight of women and men living with stage IV metastatic breast cancer. At the time of METAvivor’s founding, no organization was dedicated to funding research for the disease and no patient groups were speaking out about the dearth of stage 4 cancer research.  While more and more people have taken up the cry for more stage 4 research, METAvivor remains the sole US organization dedicated to awarding annual metastatic breast cancer research grants.

The Southwest Florida Metsquerade is one of many Metsquerades to sweep the nation and is dedicated to funding research for metastatic breast cancer (MBC). This is the only event of its kind where 100% of donations go to metastatic breast cancer research.

 

The Latest Developments Reported at the 41st Annual San Antonio Breast Cancer Symposium (SABCS)

Learn about developments from the 2018 San Antonio Breast Cancer Symposium (SABCS). SABCS is designed to provide state-of-the-art information on the experimental biology, etiology, prevention, diagnosis, and therapy of breast cancer and premalignant breast disease, to an international audience of academic and private physicians and researchers.

Topics Covered:
  • Overview of Breast Cancer
  • New Research Presented at the San Antonio Breast Cancer Symposium (SABCS)
  • Breast Cancer-Specific Treatment Updates
  • Investigational New Drugs in Clinical Trials
  • Questions for Our Panel of Experts

San Antonio Breast Cancer Symposium (SABCS)

SABCS is designed to provide state-of-the-art information on the experimental biology, etiology, prevention, diagnosis, and therapy of breast cancer and premalignant breast disease, to an international audience of academic and private physicians and researchers.

SABCS welcomes attendance by informed patient advocates representing recognized patient advocacy, education & survivor support organizations.

5th Annual Metastatic Breast Cancer Conference- Baltimore

The mission of the 5th Annual Metastatic Breast Cancer Conference is to bring together a diverse audience to create a collaborative research environment with a long term goal of developing curative approaches for metastatic breast cancer patients.The Metastatic Breast Cancer Conference was established in 2014 as an annual medical conference for metastatic breast cancer by Theresa’s Research Foundation with leadership from Dr. Matthew Ellis and Dr. Danny Welch. The specific focus on metastatic disease is based on a major unmet clinical need (incurability); thereby distinguishing this conference from other breast cancer-centered conferences. The first conference was hosted at the University of Kansas Cancer Center. In 2015, 2016 and 2017 the MBCC was hosted at Baylor College of Medicine.

The objectives of the conference are to:

  1. Improve palliative care and end of life counseling for patients with metastatic breast cancer.
  2. Implement evidence-based recommendations for treatment of metastatic breast cancer and its subtypes.
  3. Describe how clinical trials can help improve treatment of metastatic breast cancer.
  4. Discuss how drug resistance pathways can be applied to the treatment of metastatic breast cancer in order to improve outcomes and quality of life.
  5. Discuss how biomarkers and genomic analysis can be applied to the treatment of metastatic breast cancer in order to improve outcomes and quality of life.

Updates in Treatments for TNBC

Click HERE for a recording of the webinar

Join us to learn about the latest treatment updates for triple-negative breast cancer, for both early-stage and metastatic disease. We will cover the PARP inhibitors recently approved by the FDA, as well as other therapies in the pipeline. During this free webinar, you will learn what those treatments could mean for you, what information you need to make treatment decisions and how to discuss your options with your healthcare provider.

This webinar will begin with a 30- minute discussion with Rita Nanda, MD, about triple-negative breast cancer treatments for today and tomorrow. The remaining 30 minutes will be an interactive Q&A for participant comments and questions.

Know What Your Doctors Know: Metastatic Breast Cancer Webinar

Join experts as they discuss treatment options, goals, and decisions for metastatic breast cancer. This event is designed for women with metastatic breast cancer, their caregivers, and their families.

Presenters:

Karen Lisa Smith, MD, MPH
Assistant Professor of Oncology
The Sidney Kimmel Comprehensive Cancer Center at John Hopkins

Lillie D. Shockney, RN, BS, MAS, ONN-CG
University Distinguished Service Professor of Breast Cancer
Professor of Surgery and Oncology, JHU School of Medicine
Adm Director, Johns Hopkins Breast Center

Up ↑